360569-99-9Relevant academic research and scientific papers
TUBULYSIN ANALOGS AND METHODS FOR THEIR PREPARATION
-
Page/Page column 107; 108, (2017/12/27)
The present invention is directed to novel cytotoxic tubulysin analogs and derivatives, to antibody drug conjugates thereof, and to methods for using the same to treat medical conditions including cancer.
Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2
Dhanak, Dashyant,Christmann, Lisa T,Darcy, Michael G,Keenan, Richard M,Knight, Steven D,Lee, Judithann,Ridgers, Lance H,Sarau, Henry M,Shah, Dinubhai H,White, John R,Zhang, Lily
, p. 1445 - 1450 (2007/10/03)
Highly potent CCR3 antagonists have been developed from a previously reported series of phenylalanine ester-based leads. Solution-phase, parallel synthesis optimization was utilized to identify highly potent, functional CCR3 antagonists.
